IP Library › Granted Patent US 12,479,798
Granted Patent B2
US 12,479,798 · App. 17/777,943 · Granted Nov 25, 2025

Method for producing pyrrolidine compound

Inventors: Atsuko Nishiguchi (Osaka, JP); Yoshihiro Banno (Kanagawa, JP)
Assignee: Takeda Pharmaceutical Company Limited
C07D207/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,479,798
App. No.
17/777,943
Granted
Nov 25, 2025
Kind
B2
Abstract

The present invention provides a production method suitable for industrial production of (2S,3S)-3-amino-2-(3-bromo-2-fluorobenzyl)pyrrolidine having a protecting group at the 1-position. The present invention is a method for producing N-[(4-methylphenyl)sulfonyl]-L-phenylalanine salt of (2S,3S)-3-amino-2-(3-bromo-2-fluorobenzyl)pyrrolidine having a protecting group at the 1-position, which comprises Step 2: a step of subjecting 2-(3-bromo-2-fluorobenzyl)-3-(methoxyimino)pyrrolidine having a protecting group at the 1-position to a reduction reaction; and Step 3: a step of subjecting the product obtained in Step 2 to optical resolution using salt formation with N-[(4-methylphenyl)sulfonyl]-L-phenylalanine.

Claims (9)

1 . A method for producing N-[(4-methylphenyl)sulfonyl]-L-phenylalanine salt of (2S,3S)-3-amino-2-(3-bromo-2-fluorobenzyl)pyrrolidine having a protecting group at the 1-position, which comprises

subjecting 2-(3-bromo-2-fluorobenzyl)-3-(methoxyimino)pyrrolidine having a protecting group at the 1-position to a reduction reaction; and

subjecting the product to optical resolution using salt formation with N-[(4-methylphenyl)sulfonyl]-L-phenylalanine.

2 . The method according to claim 1 , wherein the reduction reaction is carried out in the presence of zirconium(IV) chloride.

3 . A method for producing N-[(4-methylphenyl)sulfonyl]-L-phenylalanine salt of (2S,3S)-3-amino-2-(halo-substituted benzyl)pyrrolidine having a protecting group at the 1-position, which comprises

subjecting 2-(halo-substituted benzyl)-3-(methoxyimino)pyrrolidine having a protecting group at the 1-position to a reduction reaction; and

subjecting the product to optical resolution using salt formation with N-[(4-methylphenyl)sulfonyl]-L-phenylalanine.

4 . The method according to claim 3 , wherein the reduction reaction is carried out in the presence of zirconium(IV) chloride.

5 . The method of claim 3 further comprising reacting 2-(halo-substituted benzyl)-3-oxopyrrolidine having a protecting group at the 1-position with O-methylhydroxylamine or a salt thereof to provide 2-(halo-substituted benzyl)-3-(methoxyimino)pyrrolidine.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2023
From: NISHIGUCHI, ATSUKO; YABE, OSAMU
To: SPERA PHARMA, INC.
Reel/Frame 064926/0976 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2023
From: BANNO, YOSHIHIRO
To: AXCELEAD DRUG DISCOVERY PARTNERS, INC.
Reel/Frame 064927/0057 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2023
From: AXCELEAD DRUG DISCOVERY PARTNERS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 064927/0088 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2023
From: SPERA PHARMA, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 064927/0095 →
Priority Claims (1)
JP 2019-209070 · Nov 19, 2019 · national
Continuity (1)
Related Publication 20220411369A1 · Dec 29, 2022
References Cited (7)
JP 413659A · 1992 [cited by applicant]
JP 2002531558A · 2002 [cited by applicant]
JP 2022371060A · 2022 [cited by applicant]
WO WO199950261A1 · 1999 [cited by applicant]
WO WO2019027058A1 · 2019 [cited by applicant]
English Translation of International Search Report for International Appl. No. PCT/JP2020/042891 mailed Jan. 19, 2021, 2 pages. [cited by applicant]
English Translation of Written Opinion of the International Searching Authority for International Appl. No. PCT/JP2020/042891 dated Jan. 19, 2021, 3 pages. [cited by applicant]